文献速递免疫规划卫生政策与健康促进

COVID-19疫苗剂量节约策略:改善疫苗公平与大流行防范

COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness.
PubMed 文献 · Lancet Glob Health · 2022-01-01

尽管全球努力,COVID-19疫苗接种覆盖率仍滞后。疫苗剂量节约策略可增加疫苗可及性以应对全球危机,但需公私合作协调行动以快速提供科学依据。本文观点文章列举既往临床试验评估的剂量节约方法并反思其资金来源,强调需加速测试剂量节约策略,并主张建立系统识别、科学测试和最终实施剂量节约机会的机制,该机制对未来传染病产品开发和大流行防范有价值。

要点

  • 疫苗剂量节约策略可提高COVID-19疫苗可及性,应对全球接种覆盖率滞后。
  • 需公私合作协调行动,快速为剂量节约策略提供科学依据。
  • 应建立系统识别、科学测试并实施剂量节约机会的机制,以助未来大流行防范。

核心结论

  • 建立系统识别、科学测试并最终实施剂量节约机会的机制,将证明对当前大流行之外的传染病产品开发和未来大流行防范有价值。

研究设计与样本

  • 本文为观点文章,未开展系统检索或原始研究,基于既往临床试验评估的疫苗剂量节约方法进行论述。

主要发现

  • 全球COVID-19疫苗接种覆盖率仍滞后,疫苗剂量节约策略可增加疫苗可及性以应对全球危机。
  • 多项评估剂量节约的临床试验正在进行中。
  • 需公私合作协调行动,以快速为不同剂量节约策略提供坚实科学依据。
  • 应加速测试地方性或流行性传染病中的疫苗剂量节约策略。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite tremendous efforts, worldwide COVID-19 vaccination coverage is lagging. Dose-sparing strategies for COVID-19 vaccines can increase vaccine availability to address the global crisis. Several clinical trials evaluating dose sparing are currently underway. However, to rapidly provide solid scientific justification for different dose-sparing strategies, joint coordinated action involving both public and private parties is needed. In this Viewpoint, we provide examples of approaches to vaccine dose-sparing that have previously been evaluated in clinical trials to improve vaccine availability and reflect on the origin of their funding. With a focus on the current COVID-19 pandemic, we stress the need for expedited testing of vaccine dose-sparing strategies in endemic or epidemic infectious diseases. However, we argue that the establishment of a mechanism through which dose-sparing opportunities are systematically identified, scientifically tested, and ultimately implemented will prove to be valuable beyond the current pandemic for infectious diseases product development and pandemic preparedness in the future.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Roozen GVT, Roukens AHE, Roestenberg M, et al. COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness. Lancet Glob Health. 2022. PMID: 35303466. doi:10.1016/S2214-109X(22)00075-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。